Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global HPV testing and PAP test market reached a value of US$ 3.73 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 5.37 Billion by 2027, exhibiting a CAGR of 6.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. 

Human papillomavirus (HPV) is a sexually transmitted infection (STI) that causes cancer of the cervix, oropharynx, penis, and vulva. It can be detected with the support of various tests and procedures, such as HPV and Papanicolaou (PAP) test.  These assessments comprise microscopic observation of specimens and cervical, head and neck cancer screening. Amongst these, HPV tests are deployed for assessing the presence of human papillomavirus that precede the development of genital warts, whereas PAP tests are used for determining changes in the cell and the presence of abnormal cells in cervices. 

HPV Testing and PAP Test Market Trends:

The increasing prevalence of cervical cancer, especially amongst the adult demographics. due to presence of papillomavirus is facilitating the need for novel, technologically advanced, and cost-effective HPV and PAP screening, which is one of the major factors primarily driving the market growth. In line with this, the introduction of machine-assisted, plasma- and cell-free deoxyribonucleic acid (DNA) screenings to detect and monitor the treatment response of HPV-infected cancers at the early phase is acting as another growth-inducing factor. This is further supported by the continuous clinical trials, developments, and product launches by key players, such as the easy-to-use home HPV screening test, on account of the sudden outbreak of coronavirus disease (COVID-19) pandemic, is providing them with a competitive edge in the market. Other factors, such as the rapid expansion in the healthcare sector and the numerous favorable initiatives undertaken by the government bodies and the non-governmental organizations (NGOs) for sensitizing people regarding the causes of cervical cancer and the benefits of having HPV and PAP tests are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global HPV testing and PAP test market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on test type, product, application and end user.

Breakup by Test Type:

  • HPV Test
  • Pap Test
  • Co-testing
     

Breakup by Product:

  • Instruments
  • Consumables
  • Services
     

Breakup by Application:

  • Cervical Cancer Screening
  • Vaginal Cancer Screening
     

Breakup by End User:

  • Hospitals and Clinics
  • Laboratories
  • Diagnostic Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Test Type, Product, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global HPV testing and PAP test market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global HPV testing and PAP test market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global HPV testing and PAP test market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global HPV Testing and PAP Test Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Test Type
    6.1    HPV Test
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Pap Test
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Co-testing
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Product
    7.1    Instruments
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Consumables
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Services
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Application
    8.1    Cervical Cancer Screening
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Vaginal Cancer Screening
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Diagnostic Centers
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Arbor Vita Corporation
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    AstraZeneca plc
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Becton Dickinson and Company
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Biocon Limited
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    bioMérieux SA
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Danaher Corporation
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
        15.3.8    F. Hoffmann-La Roche AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
        15.3.9    Hologic Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    NURX Inc. (Thirty Madison Inc.)
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    Qiagen N.V.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Quest Diagnostics Incorporated
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
        15.3.13    Seegene Inc.
           15.3.13.1 Company Overview
           15.3.13.2 Product Portfolio
           15.3.13.3 Financials
        15.3.14    Thermo Fisher Scientific Inc.
           15.3.14.1 Company Overview
           15.3.14.2 Product Portfolio
           15.3.14.3 Financials
           15.3.14.4 SWOT Analysis

List of Figures

Figure 1: Global: HPV Testing and PAP Test Market: Major Drivers and Challenges
Figure 2: Global: HPV Testing and PAP Test Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: HPV Testing and PAP Test Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: HPV Testing and PAP Test Market: Breakup by Test Type (in %), 2021
Figure 5: Global: HPV Testing and PAP Test Market: Breakup by Product (in %), 2021
Figure 6: Global: HPV Testing and PAP Test Market: Breakup by Application (in %), 2021
Figure 7: Global: HPV Testing and PAP Test Market: Breakup by End User (in %), 2021
Figure 8: Global: HPV Testing and PAP Test Market: Breakup by Region (in %), 2021
Figure 9: Global: HPV Testing and PAP Test (HPV Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: HPV Testing and PAP Test (HPV Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: HPV Testing and PAP Test (Pap Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: HPV Testing and PAP Test (Pap Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: HPV Testing and PAP Test (Co-testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: HPV Testing and PAP Test (Co-testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: HPV Testing and PAP Test (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: HPV Testing and PAP Test (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: HPV Testing and PAP Test (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: HPV Testing and PAP Test (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: HPV Testing and PAP Test (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: HPV Testing and PAP Test (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: HPV Testing and PAP Test (Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: HPV Testing and PAP Test (Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: HPV Testing and PAP Test (Diagnostic Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: HPV Testing and PAP Test (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: HPV Testing and PAP Test (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: HPV Testing and PAP Test (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: North America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: North America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: United States: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: United States: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Canada: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Canada: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Asia-Pacific: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Asia-Pacific: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: China: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: China: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Japan: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Japan: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: India: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: India: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: South Korea: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: South Korea: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Australia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Australia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Indonesia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Indonesia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Europe: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Europe: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Germany: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Germany: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: France: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: France: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: United Kingdom: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: United Kingdom: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Italy: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Italy: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Spain: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Spain: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Russia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Russia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Latin America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Latin America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Brazil: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Brazil: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Mexico: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Mexico: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Middle East and Africa: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Middle East and Africa: HPV Testing and PAP Test Market: Breakup by Country (in %), 2021
Figure 81: Middle East and Africa: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Global: HPV Testing and PAP Test Industry: SWOT Analysis
Figure 83: Global: HPV Testing and PAP Test Industry: Value Chain Analysis
Figure 84: Global: HPV Testing and PAP Test Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: HPV Testing and PAP Test Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: HPV Testing and PAP Test Market Forecast: Breakup by Test Type (in Million US$), 2022-2027
Table 3: Global: HPV Testing and PAP Test Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 4: Global: HPV Testing and PAP Test Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: HPV Testing and PAP Test Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: HPV Testing and PAP Test Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: HPV Testing and PAP Test Market: Competitive Structure
Table 8: Global: HPV Testing and PAP Test Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028

Read More

Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028

Read More

Gastric Cancer Drugs Market by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028

Read More

Androgenetic Alopecia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Read More

Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links

4